# Phase 2 Depressive Disorder, Major trials: 56 (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 56 trials in phase 2 for Depressive Disorder, Major that are recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Recruiting Phase 2 Depressive Disorder, Major trials: 56 rows for $5, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 2 rows a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/phase-2/depressive-disorder-major

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 56
- Recruiting or not yet: 56
- Read on: November 19, 2026

## Trials

The 25 newest of 56, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 10, 2026 | NCT07928245 | A Study of Brenipatide in Participants With Major Depressive Disorder | Eli Lilly and Company | Phase 2 | Not yet recruiting | Major Depressive Disorder | 330 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07928245) |
| November 2, 2026 | NCT07908563 | Dupilumab in Major Depressive Disorder | Icahn School of Medicine at Mount Sinai | Phase 2 | Recruiting | Major Depressive Disorder | 34 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07908563) |
| October 28, 2026 | NCT07901179 | A Study to Evaluate the Safety and Efficacy of ALKS 7290 as an Adjunctive Therapy to Antidepressants in Adult Participants With Major... | Alkermes, Inc. | Phase 2 | Recruiting | Major Depressive Disorder (MDD) | 180 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07901179) |
| October 26, 2026 | NCT07895134 | Psilocybin for Depression in Veterans | VA Office of Research and Development | Phase 2 | Not yet recruiting | Major Depression | 150 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07895134) |
| September 29, 2026 | NCT07845604 | Precision Depression Adalimumab Trial | Sponsor not shown (see the record) | Phase 2 | Recruiting | Major Depressive Disorder (MDD) | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07845604) |
| August 28, 2026 | NCT07793071 | Oral Thiamine (Vitamin B1) for Depression in Children and Adolescents | Massachusetts General Hospital | Phase 2 | Not yet recruiting | Major Depressive Disorder (MDD), Thiamine, Vitamin B1, Thiamine Diphosphate (TDP), Pediatrics | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07793071) |
| August 19, 2026 | NCT07772531 | A Study to Evaluate BMS-986511 in Adults With Major Depressive Disorder | Bristol-Myers Squibb | Phase 2 | Recruiting | Major Depressive Disorder | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07772531) |
| August 4, 2026 | NCT07745569 | Assessing of Behavioral Risk and Response to Electromagnetic and Psychedelic Therapies | University of New Mexico | Phase 2 | Not yet recruiting | PTSD, PTSD - Post Traumatic Stress Disorder, Major Depression, Suicidality | 150 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07745569) |
| July 29, 2026 | NCT07734701 | Pregnenolone Treatment for Alcohol Use Disorder and Major Depressive Disorder | Sponsor not shown (see the record) | Phase 2 | Not yet recruiting | Alcohol Use Disorder (AUD), Major Depressive Disorder (MDD) | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07734701) |
| June 12, 2026 | NCT07645157 | Sertraline Combined With Multi-Strain Probiotics for Adolescent Depression | First Affiliated Hospital of Chongqing Medical University | Phase 2 | Recruiting | Major Depressive Disorder (MDD), Probiotic Intervention | 120 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07645157) |
| June 2, 2026 | NCT07621237 | A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD) | Tonix Pharmaceuticals, Inc. | Phase 2 | Recruiting | Major Depressive Episode (MDE), Major Depressive Disorder (MDD), Depression | 360 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07621237) |
| May 28, 2026 | NCT07610473 | A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression | Draig Therapeutics Ltd | Phase 2 | Recruiting | Major Depressive Disorder (MDD) | 118 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07610473) |
| May 6, 2026 | NCT07569198 | Ketamine With Dialectical Behavioural Therapy (DBT) for Suicidality in Individuals With Treatment-Resistant Depression and Borderline... | Sponsor not shown (see the record) | Phase 2 | Recruiting | Borderline Personality Disorder (BPD), Treatment-Resistant Major Depressive Disorder, Treatment-resistant Bipolar... | 120 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07569198) |
| May 1, 2026 | NCT07562191 | Inhaled DMT for Major Depressive Disorder | Universidade Federal do Rio Grande do Norte | Phase 2 | Recruiting | MDD, Major Depressive Disorder (MDD), Major Depression, Suicidal Ideation, Suicide | 140 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07562191) |
| April 20, 2026 | NCT07539805 | Efficacy and Safety of Sertraline Combined With Lactobacillus Crispatus in Adolescents With Depression | First Affiliated Hospital of Chongqing Medical University | Phase 2 | Recruiting | Major Depressive Disorder (MDD), Probiotic Intervention | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07539805) |
| April 13, 2026 | NCT07523048 | Dextromethorphan-Bupropion on Striatal Activity in Adults With Major Depressive Disorder | Sponsor not shown (see the record) | Phase 2 | Recruiting | Major Depressive Disorder (MDD) | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07523048) |
| April 6, 2026 | NCT07512284 | Mindfulness Engaged Neurostimulation for Depression (MEND II) | University of California, San Diego | Phase 2 | Recruiting | Depression, Treatment Resistant Depression, Major Depressive Disorder, Depressive Disorder, Depressive Symptoms | 120 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07512284) |
| March 25, 2026 | NCT07493317 | Neutralizing Interleukin (IL)-6 | Icahn School of Medicine at Mount Sinai | Phase 2 | Recruiting | Major Depressive Disorder | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07493317) |
| March 18, 2026 | NCT07479550 | Study of Psilocybin Under Anesthesia Controlled by EEG | Stanford University | Phase 2 | Not yet recruiting | Major Depression | 10 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07479550) |
| February 12, 2026 | NCT07405606 | Psilocybin-assisted Therapy for Comorbid Major Depressive Disorder and Alcohol Use Disorder | Centre for Addiction and Mental Health | Phase 2 | Recruiting | Major Depressive Disorder (MDD), Alcohol Use Disorder (AUD) | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07405606) |
| December 24, 2025 | NCT07300969 | A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression | Draig Therapeutics Ltd | Phase 2 | Recruiting | Major Depressive Disorder (MDD) | 300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07300969) |
| December 16, 2025 | NCT07284667 | ACP-211 Monotherapy for Major Depressive Disorder With Inadequate Antidepressant Response | ACADIA Pharmaceuticals Inc. | Phase 2 | Recruiting | Major Depressive Disorder (MDD), Depressive Disorder, Treatment-Resistant | 153 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07284667) |
| December 11, 2025 | NCT07276997 | A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder | AbbVie | Phase 2 | Recruiting | Major Depressive Disorder | 195 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07276997) |
| November 10, 2025 | NCT07226661 | Double-blind, Placebo-controlled Study in Adults With Major Depressive Disorder | Supernus Pharmaceuticals, Inc. | Phase 2 | Recruiting | Major Depressive Disorder (MDD) | 230 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07226661) |
| August 11, 2025 | NCT07115329 | A Phase 2 Study of Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder | Syndeio Biosciences, Inc | Phase 2 | Recruiting | Major Depressive Disorder | 164 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07115329) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| Icahn School of Medicine at Mount Sinai | 4 |
| Massachusetts General Hospital | 3 |
| National Institute of Mental Health (NIMH) | 3 |
| Syndeio Biosciences, Inc | 2 |
| First Affiliated Hospital of Chongqing Medical University | 2 |
| Yale University | 2 |
| Draig Therapeutics Ltd | 2 |
| Emory University | 2 |
| China Medical University Hospital | 2 |
| Mayo Clinic | 1 |
| Seaport Therapeutics | 1 |
| Autobahn Therapeutics, Inc. | 1 |
| Centre Hospitalier Universitaire Vaudois | 1 |
| University of New Mexico | 1 |
| [Tonix Pharmaceuticals, Inc.](https://specstream.ai/data/clinical-trials/company/tonix-pharmaceuticals-inc) | 1 |
| [Eli Lilly and Company](https://specstream.ai/data/clinical-trials/company/eli-lilly-and-company) | 1 |
| University of California, San Diego | 1 |
| [Alkermes, Inc.](https://specstream.ai/data/clinical-trials/company/alkermes-inc) | 1 |
| Alto Neuroscience | 1 |
| [Bristol-Myers Squibb](https://specstream.ai/data/clinical-trials/company/bristol-myers-squibb) | 1 |
| University of Southern California | 1 |
| VA Office of Research and Development | 1 |
| Brigham and Women's Hospital | 1 |
| [Supernus Pharmaceuticals, Inc.](https://specstream.ai/data/clinical-trials/company/supernus-pharmaceuticals-inc) | 1 |
| Ohio State University | 1 |

## By country

| Country | Trials |
| --- | --- |
| United States | 42 |
| Czechia | 4 |
| Canada | 4 |
| Bulgaria | 3 |
| Poland | 3 |
| Germany | 2 |
| Hungary | 2 |
| China | 2 |
| Netherlands | 2 |
| United Kingdom | 2 |
| Taiwan | 2 |
| Slovakia | 1 |
| Romania | 1 |
| Spain | 1 |
| Brazil | 1 |
| Denmark | 1 |
| Portugal | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Nicaraguan restaurants in the United States](https://specstream.ai/data/businesses/nicaraguan-restaurants/united-states)
- [Cancer treatment centers in the United States](https://specstream.ai/data/businesses/cancer-treatment-centers/united-states)
- [Plastic and reconstructive surgery practices in the United States](https://specstream.ai/data/businesses/plastic-and-reconstructive-surgery-practices/united-states)
- [Court reporters in the United States](https://specstream.ai/data/businesses/court-reporters/united-states)
- [Restaurant wholesale companies in the United States](https://specstream.ai/data/businesses/restaurant-wholesale-companies/united-states)
- [Employment agencies in the United States](https://specstream.ai/data/businesses/employment-agencies/united-states)
